ICARE Trademark

Trademark Overview


On Thursday, August 8, 2024, a trademark application was filed for ICARE with the United States Patent and Trademark Office. The USPTO has given the ICARE trademark a serial number of 98688553. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, June 9, 2025. This trademark is owned by Sanofi. The ICARE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing temporary use of non-downloadable computer software that enables users to enter, access, track, monitor and generate health and medical information, analysis, and reports in the fields of oncology, neurology, immunology, inflammatory diseases, rare diseases, and rare blood disorders; providing an interactive website featuring technology that enables users to manage diseases and disorders in the fields of oncology, neurology, immunology, inflammatory diseases, rare diseases, and rare blood disorders; none of the foregoing in the field of home health care services
icare

General Information


Serial Number98688553
Word MarkICARE
Filing DateThursday, August 8, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, June 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized wording "ICARE" to the right of which is a purple circle containing a white stylized human figure with open arms. The color black represents background, outlining, shading, and/or transparent areas and is not part of the mark.
Indication of Colors claimedThe color(s) purple and white is/are claimed as a feature of the mark.
Goods and ServicesProviding temporary use of non-downloadable computer software that enables users to enter, access, track, monitor and generate health and medical information, analysis, and reports in the fields of oncology, neurology, immunology, inflammatory diseases, rare diseases, and rare blood disorders; providing an interactive website featuring technology that enables users to manage diseases and disorders in the fields of oncology, neurology, immunology, inflammatory diseases, rare diseases, and rare blood disorders; none of the foregoing in the field of home health care services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressParis 75017
FR

Trademark Events


Event DateEvent Description
Thursday, August 8, 2024NEW APPLICATION ENTERED
Sunday, January 19, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, January 19, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 11, 2025ASSIGNED TO EXAMINER
Tuesday, February 25, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 25, 2025NON-FINAL ACTION WRITTEN
Tuesday, February 25, 2025NON-FINAL ACTION E-MAILED
Tuesday, May 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 6, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 9, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, May 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 9, 2025SUSPENSION LETTER WRITTEN
Monday, June 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 30, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 30, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, June 9, 2025LETTER OF SUSPENSION E-MAILED